With over 15 years of experience in differentiating human pluripotent stem cells down the endodermal lineage, we are experts in creating functional and mature iPS cell-derived hepatocytes. Our robust, serum-free and feeder-free differentiation protocol recapitulates liver development in vivo and is the foundation for our differentiation kits, iPS cell-derived hepatocytes, and directed differentiation to hepatocyte service. In addition to providing you with an inexhaustible supply of functional hepatocytes, we have also developed a novel maintenance medium that extends the viability and functionality of human primary hepatocytes for applications that require long culture times.
Explore our technical notes to learn more about how our unique differentiation protocol and our products support metabolic disease and drug development research.
Learn about an advancement in modeling metabolic disease with Cellartis enhanced hiPS-hepatocytes.
Learn how hiPS cell-derived hepatocytes with a 14-day assay window can support drug metabolism studies.
Cellartis Power Primary HEP Medium—a breakthrough solution for long-term intrinsic clearance studies of low-clearance drugs
View data for maintaining viable, functional human primary hepatocytes for up to four weeks.
See data on how to easily and consistently create your own hepatocytes.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2020 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.